VELTUZUMAB
UNII BPD4DGQ314

Substance Identification & Data

This profile provides standardized clinical and technical data for Veltuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BPD4DGQ314.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 728917-18-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

BPD4DGQ314

CAS Registry Number

728917-18-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VELTUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C48406

National Cancer Institute reference terminology for clinical and research data.

INN ID

8932

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

SS-91

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Veltuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VELTUZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HA20 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HA20 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HA20 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HA20 .KAPPA.-CHAIN, DIMER

VELTUZUMAB [INN]

VELTUZUMAB [MART.]

VELTUZUMAB [USAN]

VELTUZUMAB [WHO-DD]